Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Could Pricey GLP-1 Drugs Cut Healthcare Costs? The Math Isn’t Simple

News Daily News

Could Pricey GLP-1 Drugs Cut Healthcare Costs? The Math Isn’t Simple

December 09, 2024

Coronary Calcium Scoring May Help Get Semaglutide to Highest-Risk Patients

News Conference News SCCT 2024

Coronary Calcium Scoring May Help Get Semaglutide to Highest-Risk Patients

July 22, 2024

Higher Risk of Atrial Fibrillation in Retired Football Players

News Daily News

Higher Risk of Atrial Fibrillation in Retired Football Players

Michael O'Riordan

July 25, 2019

To Battle CVD in China, the ‘Healthcare Pyramid’ Must Be Flipped

News Daily News

To Battle CVD in China, the ‘Healthcare Pyramid’ Must Be Flipped

June 25, 2019

Sitting Kills, in a Dose-Response Fashion, but Regular Physical Activity Attenuates Risks

News Daily News

Sitting Kills, in a Dose-Response Fashion, but Regular Physical Activity Attenuates Risks

Yael L. Maxwell

April 25, 2019

Zero CAC Reliably Excludes CAD Among Stable, Symptomatic Patients, but Experts Debate Its Need

News Daily News

Zero CAC Reliably Excludes CAD Among Stable, Symptomatic Patients, but Experts Debate Its Need

Yael L. Maxwell

April 18, 2019

Biology in the Back Seat: EAS 2018 Opens With Calls for a Big-Picture Approach to CVD Prevention

News Conference News EAS 2018

Biology in the Back Seat: EAS 2018 Opens With Calls for a Big-Picture Approach to CVD Prevention

Yael L. Maxwell

May 07, 2018

A Dose for Doing: Healthcare Providers and Exercise Specialists Struggle With Prescribing Physical Activity

News Features

A Dose for Doing: Healthcare Providers and Exercise Specialists Struggle With Prescribing Physical Activity

Yael L. Maxwell

October 24, 2016

News Daily News

Un Panel Asesor de la FDA Recomienda por un Estrecho Margen una Indicación de Mortalidad por EAC para el Antidiabético Empagliflozina

Michael O'Riordan

June 30, 2016

News Daily News

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

Michael O'Riordan

June 30, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.